Skip to main content
Clinical Trials/KCT0003730
KCT0003730
Recruiting
未知

The diagnosis, clinical characteristics and prognostic factor of Fabry disease in the Korean population: A multicenter, prospective study

Korea University Anam Hospital0 sites2,000 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Korea University Anam Hospital
Enrollment
2000
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria
  • 1\. Conventional screening criteria: severe left ventricular hypertrophy or suspicious of HCM (Interventricular septal thickness \>13mm in transthoracic echocardiography)
  • 2\. Unexplained left ventricular hypertrophy (left ventricular mass index \= 115 g/m2 in men, \= 95 g/m2 in women)
  • With at least one of following criteria
  • \- Diastolic dysfunction
  • Diastolic dysfunction is diagnosed by American Society of Echocardiography recommendation.
  • ? At least 2 positive findings as followings:
  • 1\) Averaged E/e’ \>14
  • 2\) Septal e’ \<7cm/sec
  • 3\) Tricuspid regurgitant peak velocity \>2\.9m/sec

Exclusion Criteria

  • Exclusion criteria
  • 1\. Left ventricular hypertrophy which is caused by other mechanisms, including aortic stenosis, hypertension or diabetes.
  • 2\. Multiple myeloma
  • 3\. Congenital heart disease
  • 4\. Previous cardiac surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials